Heather A. Wakelee, MD, FASCO, Helena A. Yu, MD - Data and Decisions in Advanced NSCLC: Addressing Open Questions to Optimize Immunotherapy and Targeted Options
Toby Maher, MD, MSc, PhD - Rethinking Pulmonary Fibrosis: From Fine-Tuning Diagnosis to Illuminating Novel Pathways for Emerging Treatment Strategies
Jacob Sands, MD - Assessing the Impact of Therapeutic Advances in SCLC: Instilling New Hope and Moving in Leaps and Bounds Toward Better Outcomes
PeerView Internal Medicine CME/CNE/CPE Audio PodcastRichard S. Finn, MD - Mapping the Optimal Treatment Route in HCC: Identifying Best Practices in an Expanding Therapeutic Landscape
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastJacob Sands, MD - Assessing the Impact of Therapeutic Advances in SCLC: Instilling New Hope and Moving in Leaps and Bounds Toward Better Outcomes
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastBradley J. Monk, MD, FACS, FACOG - When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast